EP1663343B8
Application of a therapeutic substance to a tissue location using an expandable medical device
Abstract
This record has no abstract on file.
Term
Term ended
Expired 15 September 2024, 2 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| EP1007135B1 | Cites | European Patent Office (EPO) |
| WO03039612A1 | Cites | World Intellectual Property Organization (WIPO) |
| WO0032267A2 | Cites | World Intellectual Property Organization (WIPO) |
| US4702252A | Cites | United States of America |
| US5490839A | Cites | United States of America |
| US6146358A | Cites | United States of America |
| US2001014717A1 | Cites | United States of America |
| US2002165423A1 | Cites | United States of America |
33 members in 7 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 503359P | United States of America | – | |
| 50335903 | United States of America | P | |
| 50335903 | United States of America | P | |
| 2004030541 | United States of America | W | |
| 2004030541 | United States of America | W | |
| US20030503359P | – | – | – |
| WO2004US30541 | – | – | – |
Members33
| Document | Office | Kind | |
|---|---|---|---|
| WO0043051A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3475200A | Australia | A | |
| EP1148899A1 | European Patent Office (EPO) | A1 | |
| US2002050661A1 | United States of America | A1 | |
| US6395208B1 | United States of America | B1 | |
| US2002183716A1 | United States of America | A1 | |
| WO2005027996A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2005106206A1 | United States of America | A1 | |
| US2005154416A1 | United States of America | A1 | |
| US6955661B1 | United States of America | B1 | |
| EP1148899B1 | European Patent Office (EPO) | B1 | |
| AT322296T | Austria | T | |
| ATE322296T1 | Austria | T1 | |
| DE60027136D1 | Germany | D1 | |
| EP1663343A2 | European Patent Office (EPO) | A2 | |
| WO2005027996A3 | World Intellectual Property Organization (WIPO) | A3 | |
| DE60027136T2 | Germany | T2 | |
| JP2007505658A | Japan | A | |
| US2008015500A1 | United States of America | A1 | |
| WO2008144162A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US7572245B2 | United States of America | B2 | |
| US7637886B2 | United States of America | B2 | |
| EP2152349A1 | European Patent Office (EPO) | A1 | |
| US7740793B2 | United States of America | B2 | |
| US2011118703A1 | United States of America | A1 | |
| US7947015B2 | United States of America | B2 | |
| EP1663343A4 | European Patent Office (EPO) | A4 | |
| EP2152349A4 | European Patent Office (EPO) | A4 | |
| US9050442B2 | United States of America | B2 | |
| US2015273189A1 | United States of America | A1 | |
| EP2152349B1 | European Patent Office (EPO) | B1 | |
| EP1663343B1 | European Patent Office (EPO) | B1 | |
| EP1663343B8This record | European Patent Office (EPO) | B8 |
67 legal events, as 9 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Invalidation of extension of european patentsMG9D | MG9D | LT | |
| Patent invalid in the netherlands as no translation has been filedMP | MP | NL | |
| CorrectionBERICHTIGUNG B8PK | PK | CH | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Change of representativeR082 | R082 | DE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA | STAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Availability of information related to the publication of the international search reportORIGINAL CODE: 0009015PUAK | PUAK | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1663343
- Publication, DOCDB
- 1663343
- Publication, EPODOC
- EP1663343
- Application
- 784410
- Application, DOCDB
- 04784410
- Application, EPODOC
- EP20040784410
Titles3
- German
- APPLIKATION EINER THERAPEUTISCHEN SUBSTANZ AN EINE GEWEBESTELLE UNTER VERWENDUNG EINES EXPANDIERBAREN MEDIZINPRODUKTS
- English
- APPLICATION OF A THERAPEUTIC SUBSTANCE TO A TISSUE LOCATION USING AN EXPANDABLE MEDICAL DEVICE
- French
- APPLICATION D'UNE SUBSTANCE THERAPEUTIQUE SUR UNE ZONE TISSULAIRE AU MOYEN D'UN DISPOSITIF MEDICAL EXTENSIBLE
Classification
- CPC, 14
- A61L29/16
- A61L31/16
- A61L2300/606
- A61P3/06
- A61P17/18
- A61P5/00
- A61P23/00
- A61P7/02
- A61P29/00
- A61P9/00
- A61P31/00
- A61P9/12
- A61P35/00
- A61P43/00
- IPC, 11
- A61M25 00
- A61L29 16
- A61L31 16
- A61F2 06
- A61F2 82
- A61F2 958
- A61K9 22
- A61K31 225
- A61M
- A61M25 10
- A61M25 16
Designated states33
- Contracting states, 28
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Poland
- Portugal
- Romania
and 4 moreShow fewer
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 5
- Albania
- Croatia
- Lithuania
- Latvia
- North Macedonia